{"id":452528,"date":"2025-12-17T05:27:24","date_gmt":"2025-12-17T05:27:24","guid":{"rendered":"https:\/\/www.europesays.com\/us\/452528\/"},"modified":"2025-12-17T05:27:24","modified_gmt":"2025-12-17T05:27:24","slug":"medivis-first-to-receive-fda-clearance-for-augmented-reality-navigation-in-neurosurgery","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/452528\/","title":{"rendered":"Medivis First to Receive FDA Clearance for Augmented Reality Navigation in Neurosurgery"},"content":{"rendered":"

By using augmented reality to spatially map patient imaging within the operative field, the\u00a0Medivis platform gives surgeons a clear, real-time view of critical anatomy and planned trajectories. This approach can support faster, more confident decision-making during cranial procedures while minimizing workflow disruption and reducing dependence on external monitors. The platform’s portable design enables reliable image guidance in settings where conventional systems fail \u2013 especially the ICU \u2013 extending image-guided precision to a wider range of clinical environments.<\/p>\n

Today, external ventricular drains (EVDs) are misplaced at rates reported as high as 30%, often leading to repeated passes, patient harm, and delayed critical care. By providing real-time, AR-guided visualization at the bedside, early clinical experience suggests Medivis can significantly reduce these misplacements \u2013 directly improving patient safety, accelerating life-saving interventions, and raising the standard of care across neurosurgery.<\/p>\n

“For the first time, neurosurgeons can perform cranial procedures using augmented reality \u2013 merging the digital and physical worlds with high-accuracy guidance,” said Dr. Osamah Choudhry, CEO and co-founder of Medivis. “This is a profound milestone not only for Medivis, but for the entire field of neurosurgery. With this clearance, we’re bringing image-guided navigation to the ICU, where it hasn’t been possible before, giving clinicians greater precision at the bedside and helping support safer care for patients, while paving the way for full integration into operating rooms.”<\/p>\n

“This achievement reflects an extraordinary collaboration between our team and the FDA, whose leadership and shared commitment to elevating patient care made this innovation possible,” said Dr. Christopher\u00a0Morley, President and co-founder of Medivis. “This milestone not only attests to our technology’s capabilities but also lays the foundation for broad deployment of AR guidance across ICUs, operating rooms, and surgical centers worldwide \u2013 advancing a future where surgical intelligence improves outcomes in every clinical setting.”<\/p>\n

Medivis’ Cranial Navigation<\/a>\u00a0sets a new standard in neurosurgery, delivering advanced capabilities that can support enhanced precision, safety, and efficiency:<\/p>\n